MAIA
MAIA Biotechnology Inc

2,235
Loading...
Loading...
News
all
press releases
News Placeholder
MAIA’s New Agreement With Big Pharma Roche Turns Retail Investors Bullish As Stock Soars
The agreement aims to support future studies investigating the combination of MAIA’s Ateganosine and Roche’s checkpoint inhibitor, Atezolizumab, for safe and effective cancer treatments.
Stocktwits·3mo ago

Latest MAIA News

View

Advertisement. Remove ads.

Advertisement. Remove ads.